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   Subtypes
        A Spindle cell : medullary
        AB Mixed
        B1 Lymphocyte-rich, lymphocytic predominantly cortical : organoid
        B2 Cortical
        B3 Epithelial: atypycal : squamoid : well-defferentiated thymic carcinoma
        Others Micronodular thymoma, Metaplastic thymoma, Microscopic thymoma,
Sclerosing thymoma, and Lipofibroadenoma
 Table 1. The WHO Histological Classification of Thymoma
Stage Ⅰ Macroscopically completely encapsulated 
and microscopically no capsular invasion.
Stage Ⅱ Macroscopic or microscopic invasion into surrounding 
fatty tissue or mediastinal pleura.
Stage Ⅲ Macroscopic invasion into neighboring organ ,
i.e.pericardium,great vessels,or lung.
Stage Ⅳa Pleural or pericardial dissemination.
         Ⅳb Lymphatic or hematogeneous metastases.
Table 2. The Masaoka Staging System
Patient Age Masaoka WHO  Postoperative  Postoperative  Follow-up
no. (years) stage subtype  radiotehrapy myathenia gravis  interval (months)
1 42 F 7.0 I AB — — — 60
2 52 F 4.0 I B1 — — — 81
3 35 F 6.8 I B2 — — — 28
4 30 F 11.5 I B2 — — — 20
5 57 F 6.0 I B2 — — — 105
6 46 F 7.0 I B2 — — — 54
7 59 F 3.0 I B2 — — — 88
8 71 M 4.0 I B2 — — — 152
9 60 M 6.3 II A Yes — — 70
10 65 M 7.5 II B1 — — — 76
11 56 F 7.0 II B1 Yes — — 211
12 57 M 7.5 II B1 Yes — — 205
13 62 F 7.0 II B2 — — — 76
14 70 M 6.0 II B2 — Yes — 136
15 70 M 6.3 II B2 — — — 93
16 72 M 4.2 II B2 Yes — — 141
17 46 F 2.5 II B3 Yes — — 78
18 64 F 3.5 II B3 — — Yes 201
Maximal size ; maximal diamer of tumor in resected materals,  M ; male,  F ; female,   TR ; tumor resection, 
Table 3.  Patients' Characteristics in the Limited Thymectomy Group
Maximal
size (cm) RecurrenceGender
WHO subtype ; World Health Organization histologic classification subtypes
Limited Thymectomy Group Total Thymectomy Group p  value
Total 18 61 —
Gender (Male / Female) 6 ⁄ 12 29 ⁄ 32 NS
Age (yers) 54.7 ± 12.4 56.2 ± 13.1 NS
Maximal size of tumor (cm) 6.1 ± 2.1 5.0 ± 2.9 NS
Preoperative MG 1 27 p  < 0.01
Masaoka staging  I ⁄ II 8 ⁄ 10 17 ⁄ 44 NS
WHO subtypes  
  type A / AB / B1 / B2 / B3 / others or unknown
Postoperative radiotherapy 
  Number of patients (%) 5 (27.8) 19 (31.1) NS
  Total dose (Gy) 48.7 ± 2.5 48.1 ± 2.8 NS
Follow-up interval (months) 104.2 ± 58.1 67.3 ± 54.8 p  < 0.05
Data are shown as mean ± SD,  NS ; not significant,   MG ; myasthenia gravis
1 / 1 / 4 / 10 / 2 / 0 5 / 15 / 12 / 19 / 9 / 3 NS
Table 4. Comparison of Patients Profile Between Limited and Total Thymectomy 
Limited Thymectomy Group Total Thymectomy Group p  value
Number of patients 18 61 —
Postoperative MG 1 0 0.16
Multple lesion 0 2 0.47
Death case 0 3 —
Recurrence case (95% CI) 1 (0.291 - 29.4) 0 ( 0.00 - 7.38) 0.064
Overall 10-yr ssurvival rate (95% CI) 100 (100 - 100) 82.0 (62.9 - 100) 0.17
 
Disease free 10-yr survival rate (95% CI) 85.7  (59.8 - 100) 82.0 (62.9 - 100) 0.64
Table 5. Comparison of Surgical Outcome
               between Limited and Total Thymectomy Group
MG ; myasthenia gravis,  CI ; confidence interval
Group PostRT (+) PostRT (-) Overall
Limited Thymectomy 0 ⁄ 6  1 ⁄ 12 1 ⁄ 18
Total Thymectomy 0 ⁄ 18 0 ⁄ 43 0 ⁄ 61
Overall 0 ⁄ 24 1 ⁄ 55 1 ⁄ 79
Recurrence / n
               and Postoperative Radiotherapy
Table 6.  Reccurent Case depending on the Operation Methods
  n ; numbers of case in the corresponding criteria,   PostRT ; postoperative radiotherap
